HOME >> MEDICINE >> NEWS
Newer lung cancer treatments extend survival longer than traditional regimens

Patients with advanced non-small cell lung cancer who are treated with regimens containing paclitaxel and carboplatin survive longer than patients treated with older cisplatin-based regimens or supportive care, a new study finds.

"While advanced lung cancer remains incurable, this study provides additional evidence that paclitaxel- and carboplatin-based regimens can prolong survival of patients with this disease," said John Hainsworth, MD, lead study author and Director of Clinical Research at the Sarah Cannon Cancer Center. "Survival beyond two years has been uncommon with previous treatments for advanced non-small cell lung cancer. With these newer regimens, two-year survival is similar to what we used to see at one year with the best supportive care or older regimens."

This study provides long-term follow-up on 321 patients with newly-diagnosed stage IIIB or IV non-small cell lung cancer who were treated in one of three sequential phase II trials between March 1995 and April 1998. All three trials were conducted in The Minnie Pearl Cancer Research Network, a community-based clinical trials group. Each trial included a different treatment regimen: paclitaxel and carboplatin; paclitaxel, carboplatin and gemcitabine; and paclitaxel, carboplatin, and vinorelbine. Data from these trials were compared retrospectively to previous studies on supportive care or traditional cisplatin-based regimens.

After an average follow-up of 58 months, actual one-, two-, and three-year survival rates were 40 percent, 19 percent, and 7 percent, respectively. The actuarial four-year survival rate for the entire group was four percent.

When compared retrospectively to older cisplatin-based regimens (not containing a taxane), these paclitaxel- and carboplatin-based treatments increase one-year survival from 25 to 30 percent, to 35 to 40 percent. These regimens also improve survival substantially when compared to the 16 percent one-year survival rate
'"/>

Contact: Stacia Momburg
momburgs@asco.org
703-299-1014
American Society of Clinical Oncology
27-Jun-2002


Page: 1 2

Related medicine news :

1. Newer formulation of heparin improves outcomes for suspected heart attack patients
2. Newer rheumatoid arthritis drugs: Harmful on the liver?
3. Newer vitamin D formulation appears to help dialysis patients live longer
4. Newer form of gold standard drug helps kidney transplant patients do better in long term
5. Physicians Slow To Adopt Newer Drugs For Atrial Fibrillation
6. Hormonal treatment improves survival in high-risk prostate cancer patients
7. International breast cancer prevention study launches in the United States and Canada
8. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo
9. Cultural and social factors influence prostate cancer treatment
10. Primary care office strategies may increase colon cancer screening
11. Benefits of lung cancer screening with CT questioned

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/16/2019)... ... March 16, 2019 , ... Blood Flow ... Ligament (ACL) reconstruction patients often face bone and muscle loss immediately following the ... note that combining blood flow restriction (BFR) therapy with traditional rehabilitation efforts may ...
(Date:3/15/2019)... ... March 15, 2019 , ... ... announced the launch of its newly designed healthcare website, SMG3RX.com. Integrating a vibrant ... easily find a solution that fits their needs. , “We are thrilled to ...
(Date:3/15/2019)... ... March 15, 2019 , ... Esteemed Marietta dentist Dr. Michael ... Dental Assisting . The private dental assistant school is recognized as one of the ... a position within sixty days of graduation. Assisting 101 - School of Dental Assisting ...
(Date:3/15/2019)... ... 15, 2019 , ... The National Association of Chain Drug ... seven-day supply the initial prescriptions of opioids for acute pain – a move ... for prescribing opioids. , U.S. Sen. Kirsten Gillibrand (D-NY) and U.S. Sen. Cory ...
(Date:3/14/2019)... ... March 14, 2019 , ... When:    Wednesday, ... at Midtown - 1900 Long Beach Blvd., Long Beach, CA 90806 , What:    Los ... Housing, county and city officials, and other partners to celebrate the start of ...
Breaking Medicine News(10 mins):
(Date:3/14/2019)... ... ... Healthy Hemp Oil, an online provider of CBD hemp oil products, announces ... CBD products from Weller , Purfurred, Abinoid Botanicals, and Colorado Hemp Honey. , ... formulated for pets. Purfurred uses full-spectrum hemp oil and organic ingredients studied ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... their viscoelastic disc replacement. The CE Mark approval was received as a result ... and biomechanical cervical disc testing and supporting clinical data regarding the viscoelastic AxioMed ...
(Date:3/13/2019)... , ... March 13, 2019 , ... American Friends of ... its seventh annual benefit dinner on April 3, 2019, at the Pierre Hotel in ... celebrate Soroka Medical Center’s successes in fostering scientific and medical innovation in the service ...
Breaking Medicine Technology:
Cached News: